• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新西兰的棘阿米巴角膜炎,包括两例对聚六亚甲基双胍产生体内耐药性的病例。

Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.

作者信息

Murdoch D, Gray T B, Cursons R, Parr D

机构信息

Eye Department, Auckland Hospital, New Zealand.

出版信息

Aust N Z J Ophthalmol. 1998 Aug;26(3):231-6. doi: 10.1111/j.1442-9071.1998.tb01317.x.

DOI:10.1111/j.1442-9071.1998.tb01317.x
PMID:9717755
Abstract

BACKGROUND

Acanthamoeba keratitis is an uncommon corneal infection that can run a protracted course with, at times, serious visual results. Eighty-five per cent of cases occur in soft contact lens wearers. The first New Zealand case occurred in 1990 and only seven cases have been identified in New Zealand to the end of 1996.

METHODS

We surveyed the ophthalmologists looking after these seven cases of acanthamoeba keratitis as to time to diagnosis, treatment and outcome.

RESULTS

New Zealand has a low incidence of this disease. All cases were soft contact lens wearers with defective care in every instance. After an initial two late-diagnosed cases, the time to diagnosis for four of the five other cases has been within 2 weeks. Medical treatment has varied over this series, but since the introduction of the cationic antiseptics polyhexamethylene biguanide (PHMB) and chlorhexidine in 1992, the last five cases were all treated with PHMB. One case diagnosed within 2 weeks ran a devastating course, despite intensive PHMB, and a second case remained culture positive after 1 year of PHMB and the late addition of chlorhexidine. Debridement, 0.1% PHMB and hexamidine eventually settled this eye.

CONCLUSIONS

For treatment PHMB, hexamidine rather than propamidine and surgical debridement are favoured. While all Acanthamoeba isolates show good in vitro sensitivity to PHMB, the in vivo response is not always proportionate. A bacterial endosymbiont may have been a factor in the favourable outcome of one protracted case.

摘要

背景

棘阿米巴角膜炎是一种罕见的角膜感染疾病,病程可能迁延不愈,有时会导致严重的视力损害。85%的病例发生在软性隐形眼镜佩戴者中。新西兰首例病例于1990年出现,截至1996年底,新西兰仅确诊7例。

方法

我们就这7例棘阿米巴角膜炎病例的诊断时间、治疗方法及治疗结果对负责诊治的眼科医生进行了调查。

结果

新西兰该病发病率较低。所有病例均为软性隐形眼镜佩戴者,且每次护理均存在缺陷。最初有2例诊断较晚,之后5例中的4例诊断时间在2周内。在这一系列病例中,治疗方法各不相同,但自1992年引入阳离子防腐剂聚六亚甲基双胍(PHMB)和氯己定以来,最后5例均采用PHMB治疗。1例在2周内确诊的病例,尽管接受了强化的PHMB治疗,病情仍严重恶化;另1例在接受PHMB治疗1年后培养仍呈阳性,后期加用氯己定后才转阴。清创术、0.1%的PHMB和己脒最终使该眼病情得到缓解。

结论

在治疗方面,PHMB、己脒优于丙脒,手术清创也较为常用。虽然所有棘阿米巴分离株在体外对PHMB均表现出良好的敏感性,但体内反应并不总是与之成正比。一种细菌内共生体可能是1例迁延性病例取得良好治疗效果的一个因素。

相似文献

1
Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.新西兰的棘阿米巴角膜炎,包括两例对聚六亚甲基双胍产生体内耐药性的病例。
Aust N Z J Ophthalmol. 1998 Aug;26(3):231-6. doi: 10.1111/j.1442-9071.1998.tb01317.x.
2
Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.持续性培养阳性棘阿米巴角膜炎:体内耐药性与体外敏感性
Ophthalmology. 2003 Aug;110(8):1593-600. doi: 10.1016/S0161-6420(03)00481-0.
3
Successful medical treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的成功医学治疗。
Int Ophthalmol. 1997;21(4):223-7. doi: 10.1023/a:1006055918101.
4
Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.聚六亚甲基双胍治疗棘阿米巴角膜炎
Ophthalmology. 1992 Feb;99(2):185-91. doi: 10.1016/s0161-6420(92)31994-3.
5
Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.聚六亚甲基双胍和氯己定作为单药治疗棘阿米巴角膜炎的比较。
Am J Ophthalmol. 2008 Jan;145(1):130-5. doi: 10.1016/j.ajo.2007.08.040. Epub 2007 Nov 8.
6
[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].[棘阿米巴角膜炎的治疗:可能性、问题及新方法]
Wien Klin Wochenschr. 2003;115 Suppl 3:10-7.
7
Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.双侧棘阿米巴角膜炎伴角膜移植术后感染晚期复发:1例报告
Eur J Ophthalmol. 2003 Apr;13(3):311-4. doi: 10.1177/112067210301300312.
8
Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine.用聚六亚甲基双胍和丙脒治疗棘阿米巴角膜炎的结果
Ophthalmology. 1997 Oct;104(10):1587-92. doi: 10.1016/s0161-6420(97)30092-x.
9
Acanthamoeba keratitis: a sobering case and a promising new treatment.棘阿米巴角膜炎:一个发人深省的病例及一种有前景的新疗法。
Aust N Z J Ophthalmol. 1994 Feb;22(1):73-6. doi: 10.1111/j.1442-9071.1994.tb01700.x.
10
Acanthamoeba keratitis in Porto Alegre (southern Brazil): 28 cases and risk factors.阿雷格里港(巴西南部)的棘阿米巴角膜炎:28例病例及危险因素
Parasitol Res. 2018 Mar;117(3):747-750. doi: 10.1007/s00436-017-5745-y. Epub 2018 Jan 14.

引用本文的文献

1
PLGA nanoparticles loaded with Gallic acid- a constituent of Leea indica against Acanthamoeba triangularis.载没食子酸的 PLGA 纳米粒——印度榆树叶的一种成分,用于抗棘阿米巴原虫。
Sci Rep. 2020 Jun 2;10(1):8954. doi: 10.1038/s41598-020-65728-0.
2
Drug Discovery against Infections: Present Knowledge and Unmet Needs.抗感染药物研发:当前认知与未满足的需求
Pathogens. 2020 May 22;9(5):405. doi: 10.3390/pathogens9050405.
3
The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.抗真菌药物伊曲康唑对福氏耐格里阿米巴具有杀阿米巴原虫和杀包囊的作用。
Antimicrob Agents Chemother. 2020 Apr 21;64(5). doi: 10.1128/AAC.02223-19.
4
Ursolic Acid Derivatives as Potential Agents Against Spp.熊果酸衍生物作为抗**种**的潜在药物
Pathogens. 2019 Aug 23;8(3):130. doi: 10.3390/pathogens8030130.
5
The Development of Drugs against Acanthamoeba Infections.抗棘阿米巴感染药物的研发
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6441-6450. doi: 10.1128/AAC.00686-16. Print 2016 Nov.
6
Artemisia annua L. as a plant with potential use in the treatment of acanthamoebiasis.青蒿作为一种具有治疗棘阿米巴病潜在用途的植物。
Parasitol Res. 2016 Apr;115(4):1635-9. doi: 10.1007/s00436-016-4902-z. Epub 2016 Jan 19.
7
Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation.蛋白酶激活受体2(PAR2)在眼部感染和炎症中的作用。
Receptors Clin Investig. 2014;1(6). doi: 10.14800/rci.291.
8
Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga.新型阳离子碳硅烷树枝状大分子对多食棘阿米巴滋养体和包囊活性的评估。
Parasitol Res. 2015 Feb;114(2):473-86. doi: 10.1007/s00436-014-4205-1. Epub 2014 Oct 31.
9
Anti-amoebic properties of carbonyl thiourea derivatives.羰基硫脲衍生物的抗阿米巴特性。
Molecules. 2014 Apr 22;19(4):5191-204. doi: 10.3390/molecules19045191.
10
Evaluation of inhibitory potential of some selective methanolic plants extracts on biological characteristics of Acanthamoeba castellanii using human corneal epithelial cells in vitro.评价几种选择性甲醇植物提取物对体外人角膜上皮细胞中棘阿米巴 castellanii 生物学特性的抑制潜力。
Parasitol Res. 2013 Mar;112(3):1179-88. doi: 10.1007/s00436-012-3249-3. Epub 2013 Jan 10.